A New Drug Application (NDA) is a comprehensive document submitted to a regulatory agency, such as the FDA, to request approval for marketing a new drug. The NDA includes all data from preclinical and clinical trials, information on the drug’s manufacturing process, and proposed labeling. It is meticulously reviewed to ensure the drug meets all safety and efficacy standards.
